BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3014873)

  • 1. Use of sodium bicarbonate vials or syringes to buffer cardioplegic solutions.
    Miller LG; Gardner SN
    Am J Hosp Pharm; 1986 Jun; 43(6):1416, 1420. PubMed ID: 3014873
    [No Abstract]   [Full Text] [Related]  

  • 2. Supraphysiological levels of magnesium in cardioplegic arrest solutions: is there cause for concern?
    Tyers GF
    Can J Cardiol; 1995 Jan; 11(1):21-2. PubMed ID: 7850660
    [No Abstract]   [Full Text] [Related]  

  • 3. Composition of cardioplegic solutions used in nine medical centers.
    Klamerus KJ; Munger MA
    Am J Hosp Pharm; 1986 Jun; 43(6):1479-82. PubMed ID: 3487977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Important electrophysiological changes, in subjects with implanted pacemakers, occurring during extracorporeal circulation and with a cardioplegic solution. Experimental study in dogs].
    Costa R; Pêgo-Fernandes PM; Brito PL; Moreira LF; Stolf NA; Jatene AD; Armelin E
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(3):115-9. PubMed ID: 4095439
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of procaine on the pH of buffered and unbuffered cardioplegic solutions.
    Loucas SP; Maager P; Mehl B
    Am J Hosp Pharm; 1986 Sep; 43(9):2213-8. PubMed ID: 3766575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of the oxygenation of cardioplegic solutions for myocardial protection in cardiac surgery].
    Gomes OM
    Arq Bras Cardiol; 1984 Dec; 43(6):389-96. PubMed ID: 6537762
    [No Abstract]   [Full Text] [Related]  

  • 7. [Perfluorochemicals (FDA-20%, fluosol), available as cardioplegic solution].
    Nomoto S; Inoue K; Horiuchi M; Yokokawa H; Takaba T; Ishii J
    Kokyu To Junkan; 1985 Nov; 33(11):1355-60. PubMed ID: 4095390
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of halothane on post-cardioplegic functional recovery--the role of cardioplegic solution.
    Genade S; Tromp E; Lochner RC; Lochner A
    S Afr Med J; 1998 Apr; 88 Suppl 2():C96-8. PubMed ID: 9595004
    [No Abstract]   [Full Text] [Related]  

  • 9. eComment: myocardial protection: efficacy of a novel magnesium-basedcardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
    Bockeria LA; Movsesyan RR; Ryabtsev DV; Grigoryants TR
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):749. PubMed ID: 18801803
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintenance of cardiac glutathione levels after cold ischemia.
    Magovern JA; Martin LF; Pae WE; Miller CA; Answine J; Grotyohann LW; Scaduto RC
    Curr Surg; 1988; 45(1):31-3. PubMed ID: 3345683
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts.
    Myers CL; Weiss SJ; Kirsh MM; Shepard BM; Shlafer M
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):281-9. PubMed ID: 3945095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium and cardioplegia. The optimal calcium content for the St. Thomas' Hospital cardioplegic solution.
    Yamamoto F; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Jun; 87(6):908-12. PubMed ID: 6727412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Difference of responses to a cardioplegic solution between the immature and the mature myocardium].
    Watanabe H; Yokosawa T; Miyamura H; Eguchi S
    Kyobu Geka; 1987 Jul; 40(8):615-9. PubMed ID: 3656829
    [No Abstract]   [Full Text] [Related]  

  • 14. The St. Thomas' hospital cardioplegic solution: a characterization in two species.
    Jynge P; Hearse DJ; Feuvray D; Mahalu W; Canković-Darracott S; O'Brien K; Braimbridge MV
    Scand J Thorac Cardiovasc Surg Suppl; 1981; 30():1-28. PubMed ID: 6278581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prolonged aortic occlusion in valvular surgery and myocardial protection].
    Nakayama Y; Aoki J; Irie H; Bando K; Sugawara E; Murakami T; Nawa S; Senoo Y; Teramoto S
    Rinsho Kyobu Geka; 1988 Apr; 8(2):174-7. PubMed ID: 9301829
    [No Abstract]   [Full Text] [Related]  

  • 16. [The efficacy of adding diltiazem to the St. Thomas' Hospital cardioplegic solution in the immature myocardium].
    Watanabe H; Yokosawa T; Miyamura H; Eguchi S; Imai S
    Rinsho Kyobu Geka; 1988 Oct; 8(5):460-3. PubMed ID: 9301869
    [No Abstract]   [Full Text] [Related]  

  • 17. Solutions for preservation of the heart at 0 degrees C.
    Foreman J; Pegg DE; Armitage WJ
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):867-71. PubMed ID: 3999789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of procaine hydrochloride in a cardioplegic solution containing bicarbonate.
    Synave R; Vergote A; Remon JP
    J Clin Hosp Pharm; 1985 Dec; 10(4):385-8. PubMed ID: 4093510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor heart preservation--limitations of cardioplegia and warm ischemia.
    Wicomb WN; Hill DJ; Avery JG; Collins GM
    Transplantation; 1992 Apr; 53(4):947-9. PubMed ID: 1566365
    [No Abstract]   [Full Text] [Related]  

  • 20. Replacing potassium with nicorandil in cold St. Thomas' Hospital cardioplegia improves preservation of energetics and function in pig hearts.
    Steensrud T; Nordhaug D; Husnes KV; Aghajani E; Sørlie DG
    Ann Thorac Surg; 2004 Apr; 77(4):1391-7. PubMed ID: 15063273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.